Advanced search
Publication Cover
Acta Orthopaedica Volume 81, 2010 - Issue 6
Journal homepage
917
Views
34
CrossRef citations to date
0
Altmetric
Research Article

Accelerated fracture healing in mice lacking the 5-lipoxygenase gene

Michaele B Manigrasso Department of Biochemistry and Molecular Biology, UMDNJ-New Jersey Medical School and Graduate School of Biological Sciences, Newark, NJ, USA
&
J Patrick O'Connor Department of Biochemistry and Molecular Biology, UMDNJ-New Jersey Medical School and Graduate School of Biological Sciences, Newark, NJ, USACorrespondence[email protected]
Pages 748-755 | Received 22 Feb 2010, Accepted 08 Jul 2010, Published online: 11 Nov 2010

  • Baron R, Vigney A, Neff L, Silvergate A, Santa Maria A. Processing of undecalcified bone specimens for bone histomorphometry. In: Bone histomorphometry: Techniques and hnterpretation. (Ed Recker RR). Boca Raton: CRC Press, Inc.; 1983: 13-35.
  • Bonewald LF, Flynn M, Qiao M, Dallas MR, Mundy GR, Boyce BF. Mice lacking 5-lipoxygenase have increased cortical bone thickness. Adv Exp Med Biol 1997; 433:299-302.
  • Burd TA, Hughes MS, Anglen JO. Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion. J Bone Joint Surg (Br) 2003; 85:700-5.
  • Byrum RS, Goulet JL, Griffiths RJ, Koller BH. Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses. J Exp Med 1997; 185:1065-75.
  • Capper EA, Marshall LA. Mammalian phospholipases A(2): mediators of inflammation, proliferation and apoptosis. Prog Lipid Res 2001; 40:167-97.
  • Chan C-C, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther 1999; 290:551-60.
  • Chen XS, Sheller JR, Johnson EN, Funk CD. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 1994; 372:179-82.
  • Clark CA, Schwarz EM, Zhang X, Ziran NM, Drissi H, O'Keefe RJ, Differential regulation of EP receptor isoforms during chondrogenesis and chondrocyte maturation. Biochem Biophys Res Commun 2005; 328:764-76.
  • Cottrell JA, O'Connor JP. Pharmacological inhibition of 5-lipoxygenase accelerates and enhances fracture-healing. J Bone Joint Surg (Am) 2009; 91:2653-65.
  • Cottrell JA, Meyenhofer M, Medicherla S, Higgins L, O'Connor JP. Analgesic effects of p38 kinase inhibitor treatment on bone fracture healing. Pain 2009; 142:116-26.
  • Dabrowski S, Kur J. Cloning and expression in Escherichia coli of the recombinant his-tagged DNA polymerases from Pyrococcus furiosus and Pyrococcus woesei. Protein Expr Purif 1998; 14:131-8.
  • Flynn MA, Qiao M, Garcia C, Dallas M, Bonewald LF. Avian osteoclast cells are stimulated to resorb calcified matrices by and possess receptors for leukotriene B4. Calcif Tissue Int 1999; 64:154-9.
  • Form DM, Auerbach R. PGE2 and angiogenesis. Proc Soc Exp Biol Med 1983; 172:214-8.
  • Gallwitz WE, Mundy GR, Lee CH, Qiao M, Roodman GD, Raftery M, 5-Lipoxygenase metabolites of arachidonic acid stimulate isolated osteoclasts to resorb calcified matrices. J Biol Chem 1993; 268:10087-94.
  • Garcia C, Boyce BF, Gilles J, Dallas M, Qiao M, Mundy GR, Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo. J Bone Miner Res 1996; 11:1619-27.
  • Hudson N, Balsitis M, Everitt S, Hawkey CJ. Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 1993; 34: 742-7.
  • Jakob M, Demarteau O, Suetterlin R, Heberer M, Martin I. Chondrogenesis of expanded adult human articular chondrocytes is enhanced by specific prostaglandins. Rheumatology (Oxford) 2004; 43:852-7.
  • Kennedy BP, Payette P, Mudgett J, Vadas P, Pruzanski W, Kwan M, A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J Biol Chem 1995; 270:22378-85.
  • Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 1995; 83:483-92.
  • Li M, Ke HZ, Qi H, Healy DR, Li Y, Crawford DT, A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing. J Bone Miner Res 2003; 18:2033-42.
  • Li M, Healy DR, Li Y, Simmons HA, Crawford DT, Ke HZ, Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice. Bone 2005; 37:46-54.
  • Lowe GN, Fu YH, McDougall S, Polendo R, Williams A, Benya PD, Effects of prostaglandins on deoxyribonucleic acid and aggrecan synthesis in the RCJ 3.1C5.18 chondrocyte cell line: role of second messengers. Endocrinology 1996; 137:2208-16.
  • Maniatopoulos C, Rodriguez A, Deporter DA, Melcher AH. An improved method for preparing histological sections of metallic implants. Int J Oral Maxillofac Implants 1986; 1:31-7.
  • Manigrasso MB, O'Connor JP. Characterization of a closed femur fracture model in mice. J Orthop Trauma 2004; 18:687-95.
  • Manigrasso MB, O'Connor JP. Comparison of fracture healing among different inbred mouse strains. Calcif Tissue Int 2008; 82:465-74.
  • Marcouiller P, Pelletier JP, Guevremont M, Martel-Pelletier J, Ranger P, Laufer S, Leukotriene and prostaglandin synthesis pathways in osteoarthritic synovial membranes: regulating factors for interleukin 1beta synthesis. J Rheumatol 2005; 32:704-12.
  • Martel-Pelletier J, Mineau F, Fahmi H, Laufer S, Reboul P, Boileau C, Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids. Arthritis Rheum 2004; 50:3925-33.
  • Maxis K, Delalandre A, Martel-Pelletier J, Pelletier JP, Duval N, Lajeunesse D. The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein. Arthritis Res Ther 2006; 8:R181.
  • Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995; 83:473-82.
  • Mountziaris PM, Mikos AG. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 2008; 14:179-86.
  • Murphy RC, Gijon MA. Biosynthesis and metabolism of leukotrienes. Biochem J 2007; 405:379-95.
  • Paralkar VM, Borovecki F, Ke HZ, Cameron KO, Lefker B, Grasser WA, An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Proc Natl Acad Sci U S A 2003; 100:6736-40.
  • Raisz LG. Prostaglandins and bone: physiology and pathophysiology. Osteoarthritis Cartilage 1999; 7:419-21.
  • Ren W, Dziak R. Effects of leukotrienes on osteoblastic cell proliferation. Calcif Tissue Int 1991; 49:197-201.
  • Seno H, Oshima M, Ishikawa TO, Oshima H, Takaku K, Chiba T, Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps. Cancer Res 2002; 62:506-11.
  • Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004; 56:387-437.
  • Simon AM, Manigrasso MB, O'Connor JP. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002; 17:963-76.
  • Simon AM, O'Connor JP. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Joint Surg (Am) 2007; 89:500-11.
  • Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150:76-85.
  • Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci U S A 1998; 95:13313-8.
  • Steinhilber D. 5-Lipoxygenase: enzyme expression and regulation of activity. Pharm Acta Helv 1994; 69:3-14.
  • Tanaka M, Sakai A, Uchida S, Tanaka S, Nagashima M, Katayama T, Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats. Bone 2004; 34:940-8.
  • Traianedes K, Dallas MR, Garrett IR, Mundy GR, Bonewald LF. 5-Lipoxygenase metabolites inhibit bone formation in vitro. Endocrinology 1998; 139:3178-84.
  • Wientroub S, Wahl LM, Feuerstein N, Winter CC, Reddi AH. Changes in tissue concentration of prostaglandins during endochondral bone differentiation. Biochem Biophys Res Commun 1983; 117:746-50.
  • Yu Y, Fan J, Chen XS, Wang D, Klein-Szanto AJ, Campbell RL, Genetic model of selective COX2 inhibition reveals novel heterodimer signaling. Nat Med 2006; 12:699-704.
  • Yuan C, Rieke CJ, Rimon G, Wingerd BA, Smith WL. Partnering between monomers of cyclooxygenase-2 homodimers. Proc Natl Acad Sci U S A 2006; 103:6142-7.
  • Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002; 109:1405-15.
  • Zhang X, Ziran N, Goater JJ, Schwarz EM, Puzas JE, Rosier RN, Primary murine limb bud mesenchymal cells in long-term culture complete chondrocyte differentiation: TGF-beta delays hypertrophy and PGE2 inhibits terminal differentiation. Bone 2004; 34:809-17.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.